🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

57 results for “Theravance” Clear

  1. Revefenacin

    Theravance Biopharma Ireland Umited

    Chronic Obstructive Pulmonary Disease, COPD

    phase 3 small molecule completed

    2 trials

  2. TD-1473 Dose A

    Theravance Biopharma Ireland Umited

    Ulcerative Colitis (UC)

    phase 3 small molecule terminated

    2 trials

  3. TD-4208

    Theravance Biopharma Ireland Umited

    Chronic Obstructive Pulmonary Disease (COPD)

    phase 3 small molecule completed

    4 trials

  4. ampreloxetine

    Theravance Biopharma Ireland Umited

    Symptomatic Neurogenic Orthostatic Hypotension

    phase 3 small molecule active

    4 trials

  5. 400 microgrammes GSK961081

    Theravance Biopharma Ireland Umited

    Pulmonary Disease, Chronic Obstructive

    phase 2 small molecule completed

    1 trial

  6. Placebo

    Theravance Biopharma Ireland Umited

    Chronic Obstructive Pulmonary Disease, COPD

    phase 2 small molecule completed

    1 trial

  7. Placebo

    Theravance Biopharma Ireland Umited

    Crohn's Disease

    phase 2 small molecule terminated

    1 trial

  8. Revefenacin Inhalation Solution [Yupelri]

    Theravance Biopharma Ireland Umited

    COPD

    phase 2 small molecule completed

    1 trial

  9. TD-0903

    Theravance Biopharma Ireland Umited

    Acute Lung Injury (ALI) Associated With COVID-19

    phase 2 small molecule completed

    2 trials

  10. TD-1211

    Theravance Biopharma Ireland Umited

    Healthy

    phase 2 small molecule completed

    2 trials

  11. TD-1211

    Theravance Biopharma Ireland Umited

    Opioid Induced Constipation

    phase 2 small molecule completed

    2 trials

  12. TD-1211

    Theravance Biopharma Ireland Umited

    Opioid-induced Constipation (OIC)

    phase 2 small molecule completed

    1 trial

  13. TD-1792

    Theravance Biopharma Ireland Umited

    Staphylococcal Skin Infection

    phase 2 small molecule completed

    1 trial

  14. TD-4208

    Theravance Biopharma Ireland Umited

    Chronic Obstructive Pulmonary Disease

    phase 2 small molecule completed

    1 trial

  15. TD-4208

    Theravance Biopharma Ireland Umited

    COPD

    phase 2 small molecule completed

    2 trials

  16. TD-5108

    Theravance Biopharma Ireland Umited

    Chronic Constipation

    phase 2 small molecule completed

    1 trial

  17. TD-8236

    Theravance Biopharma Ireland Umited

    Asthma

    phase 2 small molecule completed

    2 trials

  18. TD-9855

    Theravance Biopharma Ireland Umited

    Attention-Deficit/Hyperactivity Disorder

    phase 2 small molecule completed

    1 trial

  19. TD-9855

    Theravance Biopharma Ireland Umited

    Neurogenic Orthostatic Hypotension

    phase 2 small molecule completed

    1 trial

  20. TD-9855 Group 1

    Theravance Biopharma Ireland Umited

    Fibromyalgia

    phase 2 small molecule completed

    1 trial

  21. Telavancin

    Theravance Biopharma Ireland Umited

    Infection

    phase 2 small molecule completed

    1 trial

  22. Velusetrag

    Theravance Biopharma Ireland Umited

    Gastroparesis

    phase 2 small molecule completed

    1 trial

  23. velusetrag dose 1

    Theravance Biopharma Ireland Umited

    Gastroparesis

    phase 2 small molecule completed

    1 trial

  24. Ampreloxetine

    Theravance Biopharma Ireland Umited

    Symptomatic Neurogenic Orthostatic Hypertension

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources